Connection

LINGEGOWDA SELANERE MANGALA to Imatinib Mesylate

This is a "connection" page, showing publications LINGEGOWDA SELANERE MANGALA has written about Imatinib Mesylate.
  1. An anticancer C-Kit kinase inhibitor is reengineered to make it more active and less cardiotoxic. J Clin Invest. 2007 Dec; 117(12):4044-54.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.